Evidence map›Paper›PMID 24384390›Full record

ArticleDevelopmental biology2014

Retinoic acid regulation by CYP26 in vertebrate lens regeneration.

Alvin G Thomas, Jonathan J Henry

Abstract read
In one paragraph

Article in Developmental biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Challenges and Opportunities in P450 Research on the Eye.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alvin G ThomasDepartment of Cell & Developmental Biology, University of Illinois at Urbana-Champaign, 601 S. Goodwin Ave. Urbana, IL 61801, United States. Electronic address: athoma20@illinois.edu.
Jonathan J HenryDepartment of Cell & Developmental Biology, University of Illinois at Urbana-Champaign, 601 S. Goodwin Ave. Urbana, IL 61801, United States. Electronic address: j-henry4@illinois.edu.
University of Illinois Urbana-Champaign · US

Funding

MOLECULAR AND CELLULAR BASIS OF LENS DEVELOPMENTR01EY009844 · NEI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI HENRY, JONATHAN J · 1993 to 2010
$2.5M
NEI NIH HHS EY09844NEI NIH HHS R01 EY009844
6 · The paper itself

Abstract

Xenopus laevis is among the few species that are capable of fully regenerating a lost lens de novo. This occurs upon removal of the lens, when secreted factors from the retina are permitted to reach the cornea epithelium and trigger it to form a new lens. Although many studies have investigated the retinal factors that initiate lens regeneration, relatively little is known about what factors support this process and make the cornea competent to form a lens. We presently investigate the role of Retinoic acid (RA) signaling in lens regeneration in Xenopus. RA is a highly important morphogen during vertebrate development, including the development of various eye tissues, and has been previously implicated in several regenerative processes as well. For instance, Wolffian lens regeneration in the newt requires active RA signaling. In contrast, we provide evidence here that lens regeneration in Xenopus actually depends on the attenuation of RA signaling, which is regulated by the RA-degrading enzyme CYP26. Using RT-PCR we examined the expression of RA synthesis and metabolism related genes within ocular tissues. We found expression of aldh1a1, aldh1a2, and aldh1a3, as well as cyp26a1 and cyp26b1 in both normal and regenerating corneal tissue. On the other hand, cyp26c1 does not appear to be expressed in either control or regenerating corneas, but it is expressed in the lens. Additionally in the lens, we found expression of aldh1a1 and aldh1a2, but not aldh1a3. Using an inhibitor of CYP26, and separately using exogenous retinoids, as well as RA signaling inhibitors, we demonstrate that CYP26 activity is necessary for lens regeneration to occur. We also find using phosphorylated Histone H3 labeling that CYP26 antagonism reduces cell proliferation in the cornea, and using qPCR we find that exogenous retinoids alter the expression of putative corneal stem cell markers. Furthermore, the Xenopus cornea is composed of an outer layer and inner basal epithelium, as well as a deeper fibrillar layer sparsely populated with cells. We employed antibody staining to visualize the localization of CYP26A, CYP26B, and RALDH1 within these corneal layers. Immunohistochemical staining of these enzymes revealed that all 3 proteins are expressed in both the outer and basal layers. CYP26A appears to be unique in also being present in the deeper fibrillar layer, which may contain cornea stem cells. This study reveals a clear molecular difference between newt and Xenopus lens regeneration, and it implicates CYP26 in the latter regenerative process.

Indexed as

Aldehyde Dehydrogenase 1 FamilyAldehyde OxidaseAnimalsCytochrome P-450 Enzyme SystemGene Expression Regulation, DevelopmentalImmunohistochemistryLens, CrystallineReal-Time Polymerase Chain ReactionRegenerationRetinal DehydrogenaseRetinoic Acid 4-HydroxylaseReverse Transcriptase Polymerase Chain ReactionSignal TransductionTretinoinXenopus laevisXenopus ProteinsAldehyde Dehydrogenase 1 FamilyAldehyde Oxidasealdh1a2 protein, XenopusCytochrome P-450 Enzyme SystemRetinal DehydrogenaseRetinoic Acid 4-HydroxylaseTretinoinXenopus ProteinsCorneaCYP26LensRALDHRegenerationRetinoic acid

Identifiers

PMID24384390
PMCPMC3939837
OpenAlexW2078803421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.